Status and phase
Conditions
Treatments
About
This study was a randomized, double-blind, single-dose and multi-dose, placebo-controlled phase Ⅰ clinical trial. Six dose groups were planned for the SAD part of the study and four dose groups were planned for the MAD part. A total of 88 healthy subjects were included.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
88 participants in 10 patient groups
Loading...
Central trial contact
Sheng Feng, M.M
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal